Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GPGPS: a robust prognostic gene pair signature of glioma ensembling IDH mutation and 1p/19q co-deletion.

Bioinformatics (Oxford, England) - 1 Jan 2023

Cheng Lixin, Wu Haonan, Zheng Xubin, Zhang Ning, Zhao Pengfei, Wang Ran, Wu Qiong, Liu Tao, Yang Xiaojun, Geng Qingshan

Abstract excerpt

MOTIVATION: Many studies have shown that IDH mutation and 1p/19q co-deletion can serve as prognostic signatures of glioma. Although these genetic variations affect the expression of one or more genes, the prognostic value of gene expression related to IDH and 1p/19q status is still unclear. RESULTS: We constructed an ensemble gene pair signature for the risk evaluation and survival prediction of glioma based on...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Chromosome Aberrations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosomes, Human, Pair 1

Share to Glioma

Share to Mutation

Share to Prognosis

Source

Open in PubMed Open full text

Identifiers

PMID: 36637205
DOI: 10.1093/bioinformatics/btac850
PMCID: PMC9843586

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GPGPS: a robust prognostic gene pair signature of glioma ensembling IDH mutation and 1p/19q co-deletion.PMID 36637205Read ↗

Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma.Semantic proximity Read ↗

Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patientsSemantic proximity Read ↗

A 1p/19q Codeletion-Associated Immune Signature for Predicting Lower Grade Glioma Prognosis.Semantic proximity Read ↗

Association of IDH mutation and 1p19q co-deletion with tumor immune microenvironment in lower-grade gliomaSemantic proximity Read ↗

A 1p/19q Codeletion Associated Immune Signature for Predicting Lower Grade Glioma PrognosisSemantic proximity Read ↗

Next-Generation Grade and Survival Expression Biomarkers of Human Gliomas Based on Algorithmically Reconstructed Molecular Pathways.Semantic proximity Read ↗

Comparison of Low-Grade Gliomas Molecular Features and Survival by 1p/19q Codeletion in The Cancer Genome AtlasSemantic proximity Read ↗

Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.Semantic proximity Read ↗

Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.Semantic proximity Read ↗

Predictive Biomarker DPY19L1 Reduces Survival in Glioma PatientsSemantic proximity Read ↗

Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomasSemantic proximity Read ↗

Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.